Treatment symptomatic of the crisis, dizzy.

In the adult

1.5 to 2 g per day, ie 3 to 4 tablets in two doses in the morning and in the evening.
The duration of treatment varies, depending on the clinical course (between 10 days and 5 to 6 weeks), at the beginning of the treatment or in case of unsuccess, the dosage may be increased, without disadvantage up to 3 g Even 4 g per day.

Mode of administration

Oral use.

White tablet, biconvex and elongated form.

Class: Pharmacotherapeutic: ANTIVERTIGINOUS MECHANISM, UNKNOWN ACTION

ATC code: N07CA04.

Not applicable.

ยท Hypersensitivity to acetylleucine or to any of the excipients

Not applicable.

Not applicable.

Not applicable.

Not applicable.

Pregnancy

In view of the available data, it is preferable, as a precautionary measure, not to use acetylleucine during pregnancy regardless of the term.

Indeed, the clinical data are reassuring but still limited and the animal data do not make it possible to conclude.

Breastfeeding

In the absence of available data, it is preferable not to use acetylleucine during breastfeeding

Very rarely: rashes, skin (sometimes associated with pruritus), urticaria

Treatment symptomatic of the crisis, dizzy.